Time BioVentures

What is Time BioVentures?

Time BioVentures is a venture capital firm specializing in investments within the biotechnology, health technology, fitness, medical devices, hospital services, healthcare, wellness, consumer, and pharmaceutical sectors. With a deep focus on innovation in healthcare, Time BioVentures offers not only financial investment but also visionary investment acumen and extensive experience through its core team of general partners and associates.

The fund provides seed and Series A round financing, with a minimum investment threshold of $100,000 and a maximum limit of $5,000,000.

Their investment 'sweet spot' is typically around $1,500,000.

The Time BioVentures team is comprised of experts who have a proven track record of success in the healthcare industry including renowned physician-scientists, entrepreneurs, and investors. General Partners include acclaimed recording artist and venture capital investor D.A.

Wallach, physician-scientist Tim Wright, M.D., who has developed over 20 groundbreaking therapeutics, and Ryan Moriarty, who is responsible for investment operations, LP communications, and portfolio management. Time BioVentures is supported by world-class scientific advisors, including Nobel Prize recipient Jim Allison, Ph.D., and cancer immunotherapy expert Pam Sharma, M.D., Ph.D.

Commercial advisors with substantial industry experience, like the creator of Napster and Spotify's lead investor Sean Parker, and former Chairman and CEO of WellPoint Leonard Schaeffer, complement the scientific expertise with business acumen. Time BioVentures leverages this broad network of industry leaders, scientists, and business experts to support companies they invest in and drive innovative solutions in the healthcare sector.